# Study of Dentoxol® Mouthrinse for Oral Mucositis

> **NCT02885376** · PHASE2 · COMPLETED · sponsor: **Ingalfarma SpA** · enrollment: 108 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DEVICE:** Dentoxol
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02885376
- **Lead sponsor:** Ingalfarma SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-08
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2018-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02885376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02885376, "Study of Dentoxol® Mouthrinse for Oral Mucositis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02885376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*